Fluid Biomarkers for Predicting the Prognosis of Liver Cirrhosis

Abstract EN

Liver cirrhosis is the terminal stage of most chronic liver conditions, with a high risk of mortality.

Careful evaluation of the prognosis of cirrhotic patients and providing precise management are crucial to reduce the risk of mortality.

Although the liver biopsy and hepatic venous pressure gradient (HVPG) can efficiently evaluate the prognosis of cirrhotic patients, their application is limited due to the invasion procedures.

Child-Pugh score and the model for end-stage liver disease (MELD) score had been widely used in the assessment of cirrhotic prognosis, but the defects of subjective variable application in Child-Pugh score and unsuitability to all phases of liver cirrhosis in MELD score limit their prognostic values.

In recent years, continuous efforts have been made to investigate the prognostic value of body fluid biomarkers for cirrhotic patients, and promising results have been reported.

Since the collection of fluid specimens is easy, noninvasive, and repeatable, fluid biomarkers can be ideal indicators to predict the prognosis of cirrhosis.

Here, we reviewed noninvasive fluid biomarkers in different prognostic functions, including the prediction of survival and complication development.